Skip to main content
. 2020 Jun 27;9(7):564. doi: 10.3390/antiox9070564

Table 5.

Effects of treatment on the secondary outcome variables: BEPSI-K, BFI, FSS, and SF-36.

ERW
(n = 29)
MW
(n = 24)
p
Outcome Variables Mean ± SD Mean ± SD Time Group Time * Group
BEPSI-K
Baseline 1.82 ± 0.65 1.73 ± 0.51
4 weeks 1.71 ± 0.72 1.73 ± 0.51 0.553 0.907 0.511
8 weeks 1.76 ± 0.73 1.78 ± 0.56
BFI
BFI Global
Baseline 4.14 ± 2.09 4.01 ± 2.27
4 weeks 3.60 ± 1.98 3.56 ± 2.09 0.016 0.964 0.901
8 weeks 3.28 ± 2.29 3.38 ± 2.28
BFI Severity
Baseline 5.69 ± 2.06 5.36 ± 2.45
4 weeks 5.49 ± 1.77 5.14 ± 2.28 0.049 0.566 0.956
8 weeks 4.90 ± 2.32 4.71 ± 2.40
BFI Interference
Baseline 3.36 ± 2.39 3.33 ± 2.38
4 weeks 2.66 ± 2.37 2.76 ± 2.30 0.028 0.845 0.895
8 weeks 2.47 ± 2.46 2.72 ± 2.41
FSS
Baseline 3.58 ± 1.58 3.65 ± 1.68
4 weeks 3.15 ± 1.53 3.40 ± 1.67 0.172 0.928 0.489
8 weeks 3.39 ± 1.81 3.17 ± 1.65

Note: * Interaction between Time and the Group. Abbreviations: BEPSI-K, Brief Encounter Psychosocial Instrument - Korean version; BFI, brief fatigue inventory; FSS, fatigue severity scale; SF-36, 36-item short-form survey.